- In August, Kennedy said a study on autism he spearheaded had found “interventions” that could be causing autism.
- A month later, Trump and Kennedy held a joint press conference to specifically warn pregnant women against taking Tylenol without citing any scientific evidence.
- Kennedy now admits there’s “no solid data” linking Tylenol to autism.
USA TODAY, WASHINGTON – Health Secretary Robert F. Kennedy Jr. said Oct. 29 that he does not have “sufficient” evidence to link Tylenol to autism, more than a month after the White House discouraged the medicine’s use by pregnant women and young children.
Evidence does not show that Kenvue’s pain medicine Tylenol definitively causes autism but that it should still be used cautiously, President Donald Trump’s top health official told reporters. Last month the president said U.S. health officials would recommend limiting Tylenol’s use.
“The causative association with, between Tylenol given in pregnancy and the perinatal periods is not sufficient to say it definitely causes autism. But it is very suggestive,” Kennedy told reporters, citing animal, blood and observational studies.
“There should be a cautious approach to it,” he added.
Kennedy’s comments also come one day after the Texas attorney general sued Kenvue, the maker of the medicine also known as acetaminophen and which has been sold widely for decades.
Asked if Kennedy’s latest comments signaled a softening of his stance on the issue, Emily G. Hilliard, Health and Human Services press secretary, said: “It’s the same position the Secretary has had since the beginning” …
